Following the identification of over 30,000 unique MAPs, we filtered peptide-coding sequences to select those overexpressed at least 10-fold in cancer and expressed ≤2KPHM in pooled TEC samples or matched NAT, for cell lines and primary samples, respectively. The gene discussed is BRD2; the disease is cancer.